Despite Lillys statement in its Q2 report that Mounjaro lacked meaningful year-over-year comparisons, sales data for Q2 2024 was as the therapy won FDA approval on May 13, 2022 for the treatment of type 2 diabetes
Many patients ask whether Yurpeak and Mounjaro are different
Diabetologia 65(12):19251966
With professional guidance, clients can better understand their eating patterns, manage cravings, and work toward long-term weight loss goals with more confidence
Investing in your foundational health - eating nutrient-dense whole foods, prioritising lean proteins, staying hydrated, and engaging in regular exercise - can dramatically improve the effectiveness of the medication
5 Its important to note that we already have very effective, evidence-based medications that can treat OUD and AUD